Emily  Faulkner


Emily graduated with a Master of Chemistry from the University of York in 2017, completing her master’s year on industrial placement at LifeArc. Her final year project focused on the development of small molecule inhibitors of MALT1 as well as the use of fragment based drug discovery in collaboration with the dementia consortium.


Emily’s PhD focuses on the use of synthetic tools and biocatalysis to develop and elaborate fragments with potential use in fragment based drug discovery.